...
首页> 外文期刊>Annals of hematology >Primary tonsillar lymphomas according to the new World Health Organization classification: to report 87 cases and literature review and analysis.
【24h】

Primary tonsillar lymphomas according to the new World Health Organization classification: to report 87 cases and literature review and analysis.

机译:根据世界卫生组织新分类的原发性扁桃体淋巴瘤:要报告87例病例并进行文献复习和分析。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The present study aimed to define the natural history, World Health Organization (WHO) classification, prognostic factors, and treatment outcome of 87 patients with primary lymphoma of the palatine tonsil and literature review and analysis. Between 1990 and March 2008, 87 consecutive patients diagnosed with primary lymphoid malignancy of the palatine tonsil. All pathologic specimens were reviewed and reclassified according to the recent WHO classification. To investigate the association of tonsillar lymphomas with Epstein-Barr virus (EBV), in situ hybridization was performed for 24 tonsillar lymphomas (23 diffuse large B-cell lymphoma (DLBC) and one classic Hodgkin's disease) and ten normal tonsils as control group. In literature review, we found 26 major related series including 1,602 patients with primary tonsillar lymphoma. The median age of our patients was 52 years (range 11-86 years). There were 39 women and 48 men with a median follow-up of 67 months for living patients. The vast majority (95%) of patients had B-cell phenotype. DLBC was the most frequent histology. In situ hybridization revealed none of 23 DLBC to be positive for EBV. The 5-year disease-free and overall survival rates were 78.9% and 86%, respectively. In the literature review and by analyzing the data collection from 26 major reported series, the median age was 55 years and male/female ratio was 1.3:1. Intermediate grade tumors consisted of 72% of all tonsillar lymphomas and B-cell lymphomas constituted 82% of all cell immunophenotypes. The 5-year disease-free and overall survival rates were 61% and 67%, respectively. The vast majority of tonsillar lymphomas are of B-cell origin and with intermediate to high-grade histology. These neoplasms tend to present in early stage disease and to have favorable outcome. WHO classification predicts more accurately treatment outcome of patients with tonsillar lymphoma. The association of DLBC in the palatine tonsil with EBV infection is infrequent.
机译:本研究旨在确定87例with扁桃体原发性淋巴瘤患者的自然病史,世界卫生组织(WHO)分类,预后因素和治疗结果,并进行文献复习和分析。在1990年至2008年3月之间,连续87例患者被诊断出with扁桃体原发性淋巴恶性肿瘤。根据最近的WHO分类对所有病理标本进行了检查和重新分类。为了研究扁桃体淋巴瘤与爱泼斯坦-巴尔病毒(EBV)的关联,对24例扁桃体淋巴瘤(23例弥漫性大B细胞淋巴瘤(DLBC)和一种典型的霍奇金病)和十例正常扁桃体进行了原位杂交。在文献综述中,我们发现了26个主要相关系列,包括1,602例原发性扁桃体淋巴瘤患者。我们患者的中位年龄为52岁(范围11-86岁)。有39名女性和48名男性对活着的患者进行了平均67个月的随访。绝大多数(95%)患者具有B细胞表型。 DLBC是最常见的组织学。原位杂交显示23个DLBC均无EBV阳性。 5年无病生存率和总生存率分别为78.9%和86%。在文献综述中,并通过分析来自26个主要报道系列的数据收集,中位年龄为55岁,男女比例为1.3:1。中级肿瘤占所有扁桃体淋巴瘤的72%,而B细胞淋巴瘤占所有细胞免疫表型的82%。五年无病生存率和总生存率分别为61%和67%。绝大多数扁桃体淋巴瘤是B细胞起源的,具有中等至高级的组织学特征。这些肿瘤倾向于出现在早期疾病中并具有良好的预后。 WHO分类法可更准确地预测扁桃体淋巴瘤患者的治疗结果。 tons扁桃体中DLBC与EBV感染的关联很少。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号